Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | BID | P55957 | 1/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5332631 | 0.92 | KCNH2 (0.40) | HTR2ASIGMAR1ADRA1ASLC6A3 | |
| SCHEMBL140371 | 0.88 | ADRA1A (0.40) | HTR2AHDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL6468704 | 0.87 | KCNH2 (0.45) | HTR2ASIGMAR1BIDBCL2L1MCL1 | |
| SCHEMBL10894648 | 0.87 | KCNH2 (0.49) | HTR2ASIGMAR1SLC6A3 | |
| SCHEMBL7426036 | 0.87 | CYP2A6 (0.46) | — | |
| SCHEMBL8095256 | 0.87 | CYP2A6 (0.46) | — | |
| SCHEMBL7431316 | 0.85 | ABCB1 (0.44) | SMN1; SMN2 | |
| SCHEMBL8083439 | 0.85 | ABCB1 (0.44) | SMN1; SMN2 | |
| SCHEMBL10422126 | 0.85 | HTR1A (0.43) | HTR2AMAOAMAOBIDO1SMN1; SMN2 | |
| SCHEMBL8091440 | 0.82 | ABCB1 (0.52) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1404325-A2 | METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY | GUILFORD PHARMACEUTICALS INC. (US) | 2004-04-07 | — | — | EP | disclosed |
| WO-2002096420-A2 | METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY | GUILFORD PHARMACEUTICALS INC. (US) | 2002-12-05 | — | — | WO | disclosed |
| EP-1127049-A1 | BRIDGED HETEROCYCLIC DERIVATIVES | GPI NIL Holdings, Inc. (US) | 2001-08-29 | — | — | EP | disclosed |
| EP-1085854-A1 | N-LINKED SULFONAMIDE OF HETEROCYCLIC THIOESTER HAIR GROWTH COMPOUNDS AND USES | GPI NIL Holdings, Inc. (US) | 2001-03-28 | — | — | EP | disclosed |
| US-6121273-A | ISOMERASE INHIBITORS EFFECTIVE AGAINST NEUROLOGICAL DISORDERS, I.E. PARKINSON'S DISEASE, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS; SIDE EFFECT REDUCTION | GPI NIL HOLDINGS, INC (US) | 2000-09-19 | — | — | US | disclosed |
| EP-1011650-A1 | METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS | Amgen Inc., (US) | 2000-06-28 | — | — | EP | disclosed |
| EP-0859614-A4 | ROTAMASE ENZYME ACTIVITY INHIBITORS | GUILFORD PHARM INC (US) | 2000-04-26 | — | — | EP | disclosed |
| WO-2000016603-A2 | BRIDGED HETEROCYCLIC DERIVATIVES | GPI NIL HOLDINGS, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| US-6004993-A | TREATMENT OF ALOPECIA IN ANIMALS | GPI NIL HOLDINGS, INC. (US) | 1999-12-21 | — | — | US | disclosed |
| WO-1999062489-A1 | N-LINKED SULFONAMIDE OF HETEROCYCLIC THIOESTER HAIR GROWTH COMPOUNDS AND USES | GPI NIL HOLDINGS, INC. (US) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999014998-A2 | METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS | AMGEN INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| EP-0859614-A1 | ROTAMASE ENZYME ACTIVITY INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1998-08-26 | — | — | EP | disclosed |
| WO-1997016190-A1 | ROTAMASE ENZYME ACTIVITY INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1997-05-09 | — | — | WO | disclosed |